Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Life Tables01:22

Life Tables

145
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
145
Actuarial Approach01:20

Actuarial Approach

107
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
107
Applications of Life Tables01:22

Applications of Life Tables

99
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
99
Life Histories01:29

Life Histories

18.3K
Overview
18.3K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

216
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
216
Determination of Expected Frequency01:08

Determination of Expected Frequency

2.2K
Suppose one wants to test independence between the two variables of a contingency table. The values in the table constitute the observed frequencies of the dataset. But how does one determine the expected frequency of the dataset? One of the important assumptions is that the two variables are independent, which means the variables do not influence each other. For independent variables, the statistical probability of any event involving both variables is calculated by multiplying the individual...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Overview and Recent Developments in the Analysis of Multistate Processes.

Statistics in medicine·2026
Same author

Censoring and Competing Risks: Avoidable and Non-Avoidable Events. Comment to the Article "Hazards constitute key quantities for analysing, interpreting and understanding time-to-event data" by Beyersmann, Schmoor, and Schumacher.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial.

JMIR mHealth and uHealth·2025
Same author

New Serious Safety Warnings for Targeted Anticancer Agents After Their Initial FDA Approval.

Cancers·2025
Same author

Evaluation of the Implementation of Integrated Primary Care for Patients with Type 2 Diabetes and Hypertension in Belgium, Cambodia, and Slovenia.

International journal of integrated care·2024
Same author

Person-Centred Diabetes Care: Examining Patient Empowerment and Diabetes-Specific Quality of Life in Slovenian Adults with Type 2 Diabetes.

Healthcare (Basel, Switzerland)·2024
Same journal

Comparison of Different Methods for the Meta-Analysis of Diagnostic Test Accuracy Studies-A Simulation Study.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

When to Adjust for Multiple Testing: A Unifying Guiding Principle.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Ensuring Quality in Preclinical Research: The Importance of Being Human.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

A Multiple Imputation Approach to Distinguish Curative From Life-Prolonging Effects in the Presence of Missing Covariates.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Tests for Categorical Data Beyond Pearson: A Distance Covariance and Energy Distance Approach.

Biometrical journal. Biometrische Zeitschrift·2026
See all related articles

Related Experiment Video

Updated: Aug 10, 2025

Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

34.5K

Expected life years compared to the general population.

Damjan Manevski1, Nina Ružić Gorenjec1, Per Kragh Andersen2

  • 1Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Biometrical Journal. Biometrische Zeitschrift
|February 14, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a new measure for calculating years lost due to disease, comparing patient survival to general population mortality. It analyzes three distinct measures, offering an R implementation for broader accessibility.

Keywords:
life years lostmortality tablesrelative survivalsurvival analysis

More Related Videos

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan
11:58

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan

Published on: June 29, 2018

9.5K
Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine
08:53

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Published on: January 26, 2024

1.1K

Related Experiment Videos

Last Updated: Aug 10, 2025

Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

34.5K
The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan
11:58

The Replica Set Method: A High-throughput Approach to Quantitatively Measure Caenorhabditis elegans Lifespan

Published on: June 29, 2018

9.5K
Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine
08:53

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Published on: January 26, 2024

1.1K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Survival Analysis

Background:

  • Quantifying disease impact often involves calculating years lost to mortality.
  • Existing measures for years lost have limitations in certain clinical or population settings.

Purpose of the Study:

  • To introduce and analyze a novel measure for calculating life years lost, suitable for situations where other methods are inappropriate.
  • To compare this new measure with two previously proposed methods, detailing their assumptions, interpretations, and estimation techniques.
  • To provide a practical R implementation for these survival analysis measures.

Main Methods:

  • Comparison of observed patient survival data against expected survival derived from external mortality tables.
  • Analysis of three distinct measures: one in a competing risk setting assuming excess hazard, and two allowing for populations with better-than-average survival.
  • Focus on the newly defined 'life years difference' measure, including variance estimation and practical challenges like extrapolation.

Main Results:

  • The study thoroughly analyzes the theoretical differences and practical applications of the three measures.
  • It highlights the utility of the new measure in specific epidemiological contexts.
  • An R package is developed, facilitating the application of all three measures.

Conclusions:

  • The newly proposed 'life years difference' measure offers a valuable alternative for quantifying disease impact, especially when comparing patient survival to general population mortality.
  • The developed R implementation enhances the accessibility and practical utility of these survival analysis tools for researchers.
  • Understanding the assumptions and interpretations of different measures is crucial for accurate epidemiological assessments.